In abstract 1159 of the 2012 abstract book (64Cu DOTA-trastuzumab [64Cu-Herceptin]/PET effectively visualizes metastatic breast cancer in HER2-positive patients. J Nucl Med. 2012;53[suppl 1]:229P), 2 names were omitted from the author list. The authors and affiliations should read as follows: “J.R. Bading, S. Tong, J. Reyes, M. Carroll, E. Poku, J.K. Miles, D. Colcher, J.E. Shively, J.Y. Wong, A. Raubitschek, J.E. Mortimer, City of Hope, Duarte, CA; P.S. Conti, University of Southern California, Los Angeles CA.”
Correction to Bading et al. 53 [suppl 1]: 229P
- © 2012 by the Society of Nuclear Medicine, Inc.